Skip to content
Free updates Login
SSCRailwayUPSC & State PSC

India–Uzbekistan Pharma–Nutraceutical Corridor Launched

15 March 20261 min read
INTERNATIONAL AFFAIRSIndia–UzbekistanPharma–NutraceuticalCorridor Launched15 March 2026safalsetu.com

Why in the news

India and Uzbekistan set up a structured corridor for trade in medicines and nutraceuticals, giving Indian makers a route into CIS countries and Eurasia.

Key facts

  • Market: Eurasian healthcare, valued at $7–10 billion.
  • Target region: Commonwealth of Independent States (CIS) and wider Eurasia.
  • Partners: Uzbekistan’s Ministry of Health, Nutrify Today and Pharma Eurasia.
  • Nature: policy-backed platform designed for regulatory alignment, investment flows and market entry.

Objectives

  • Build an institutional framework for pharma and nutraceutical trade cooperation.
  • Coordinate regulation and streamline approvals for products entering CIS markets.
  • Encourage joint ventures, partnerships and supply-chain links between Indian manufacturers and Eurasian distributors.
  • Support investment and business collaboration in healthcare.

Exam angle

  • Countries: India and Uzbekistan.
  • Region: CIS (Commonwealth of Independent States).
  • Sectors: pharmaceuticals and nutraceuticals.

Test yourself

1. Which country joined India in launching a pharma–nutraceutical trade corridor?

The corridor was launched by India and Uzbekistan.

2. The India–Uzbekistan corridor aims to tap a healthcare market of what size?

The target is a $7–10 billion Eurasian healthcare market.

3. The India–Uzbekistan corridor opens access to which grouping of markets?

It expands access to the CIS and wider Eurasia.

This topic is part of Daily Current Affairs 10 & 11 March 2026 (42 topics).

All topics of the dayDay quizMarch 2026

Read more